Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05615194Terminated
Randomised trial comparing Placebo with Dexmedetomidine (2 arms). Primary endpoint: Sevoflurane consumption. Started Dec 2022; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05615194.